Antibodies Archives

Interview 29 May 2017

Meet the Founder of the UK’s Best Biotech that Discovered Humira

Meet the founder of three hot British biotechs developing antibody-related technologies. Despite his interest in business, he remains an academic at heart. Sir Greg Winter is one of the biggest names in European biotech. As a Professor of Biochemistry at Cambridge University, he developed phage display technology that became the foundation of his first company in […]

May 29, 2017 - 9 minutesmins - By Evelyn Warner

abcam axiomx acquisition milestone antibody

More News! 18 May 2017

Abcam Makes Final Payment in the Acquisition of an US Antibody Biotech

Abcam has paid US-based AxioMx a final €4.5M milestone based on performance, completing an acquisition that totals €36.4M. Giant antibody maker Abcam, founded by star biotech entrepreneur Jonathan Milner and based in Cambridge, has announced it made the last payment part of its acquisition deal with AxioMx. The deal was initiated in November 2015 with a […]

May 18, 2017 - 1 minutemin - By Clara Rodríguez Fernández

More News! 9 May 2017

Scottish Shark Antibodies have caught Amgen’s Eye

Elasmogen and its partner Feldan Therapeutics have signed a research agreement with Amgen to develop shark-inspired antibodies delivered intracellularly. Elasmogen, based in Aberdeen, Scotland, develops soloMER‘s, which are the smallest naturally-occurring antibody binding domains. “They are remarkably stable,” Caroline Barelle told me this morning at BioTrinity in London. “They can survive extreme pH and temperatures […]

May 9, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 8 May 2017

The EU Approves New Treatment for a Rare Pediatric Cancer

Update (08/05/2017): The European Commission has granted marketing authorization to Apeiron Biologic’s APN311 in the rare pediatric cancer neuroblastoma. Originally published on 27/03/2017 Apeiron Biologics has announced that the EMA’s CHMP has recommended the approval of APN311 for immunotherapy of high-risk neuroblastoma. Apeiron Biologics is a Vienna-based biotech company developing immunological approaches to treat cancer. […]

May 8, 2017 - 3 minutesmins - By Melanie De Almeida

News and Trends 3 May 2017

Unexpected Side Effects: Are we Ready for the Rise of Immunotherapies?

As immunotherapies are moving from large academic centers to clinics across the world, doctors are realizing that releasing the breaks of the immune system comes with serious risks – and that research on its adverse effects is lagging behind. This week, AstraZeneca’s anti-PD-L1 antibody durvalumab received FDA approval to treat patients with metastatic urothelial carcinoma, making […]

May 3, 2017 - 4 minutesmins - By Melanie De Almeida

News and Trends 13 Apr 2017

Next-Gen Cancer Antibody Technology from Germany enters the Clinic

Apogenix’ partner AbbVie has started the first clinical trial for an immuno-oncology candidate with the potential to outperform antibody therapy. The German biotech Apogenix has announced that its partner AbbVie has initiated a Phase I trial testing its next-generation immuno-oncology technology in patients suffering from solid tumors, non-Hodgkin’s lymphoma (NHL) and acute myeloid leukemia (AML). The candidate […]

April 13, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 4 Apr 2017

Sample a More Efficient Sorbent to Streamline your mAb Purification

Need an efficient way to purify your antibodies but struggle to find the best column? Pall Life Sciences is giving you the opportunity to try their solution for free. Enter your email below and receive your KANEKA Protein A sorbent sample! Pall Life Sciences is giving you a chance to try for free the new, […]

April 4, 2017 - 2 minutesmins - By External Contributor

Regeneron Sanofi dupilumab Atopic Dermatitis

News and Trends 29 Mar 2017

Get Ready for One of the Biggest New Drug Approvals of the Year

After Praluent, Sanofi and Regeneron have now scored their next drug approval with dupilumab, an antibody for the treatment of atopic dermatitis. With three placebo-controlled clinical trials enrolling a total of 2119 adult participants, Sanofi and its partner Regeneron were able to convince the FDA of their new biological for the treatment of atopic dermatitis. The product of this expansive effort comes […]

March 29, 2017 - 3 minutesmins - By Melanie De Almeida

Numab Ono Pharmaceutical Immuno Oncology

News and Trends 28 Mar 2017

Swiss Antibodies Recruited by the Developer of BMS’ Cancer Blockbuster

Ono Pharmaceutical is offering the Swiss Numab €241M (CHF 258M) for the development of a multi-specific antibody for immuno-oncology applications. Numab, one of the hottest biotechs in Zurich, has developed a unique technology to generate stable antibody fragments (not an easy feat!) and use them as building blocks for multi-specific antibodies that can target up […]

March 28, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

Interview 27 Mar 2017

Meet one of the Most Successful Biotech Entrepreneurs in the UK

Jonathan Milner is a rockstar biotech entrepreneur and founder of Abcam. He is still on the board of his baby Abcam, while investing in many young startups, nurturing the British biotech ecosystem and taking part in philanthropy. Here’s my chat with him on all these topics. “I was amazed by how you could order books […]

March 27, 2017 - 7 minutesmins - By Philip Hemme

Pierre Fabre H Immune research collaboration 3

News and Trends 22 Mar 2017

France’s 2nd Biggest Pharma Enters New Partnership for Immunotherapies

With its new Fund for Innovation, Pierre Fabre will collaborate with H-Immune to use its ‘In Vitro Immunization’ (IVI) platform for the development of fully human monoclonal antibodies (mAbs). Pierre Fabre is the 2nd largest private pharmaceutical company in France and has recently made efforts to open up its innovation process. Since the establishment of the Pierre […]

March 22, 2017 - 2 minutesmins - By Melanie De Almeida

News and Trends 22 Mar 2017

What’s the Gold Standard for Therapeutic Antibodies?

Are fully human antibodies the new gold standard in therapeutic innovation? If you want to upgrade, here’s where to find them. If you’re curious about the future of antibody development, look no further than Humira. This monoclonal antibody (mAb) for various inflammatory diseases soared to become the best-selling biological in 2016. Humira is a fully human […]

March 22, 2017 - 4 minutesmins - By External Contributor

Knowledge hub

Categories

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Approaches

Therapeutic areas

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Antibodies

Meet the Founder of the UK’s Best Biotech that Discovered Humira

Abcam Makes Final Payment in the Acquisition of an US Antibody Biotech

Scottish Shark Antibodies have caught Amgen’s Eye

The EU Approves New Treatment for a Rare Pediatric Cancer

Unexpected Side Effects: Are we Ready for the Rise of Immunotherapies?

Next-Gen Cancer Antibody Technology from Germany enters the Clinic

Sample a More Efficient Sorbent to Streamline your mAb Purification

Get Ready for One of the Biggest New Drug Approvals of the Year

Swiss Antibodies Recruited by the Developer of BMS’ Cancer Blockbuster

Meet one of the Most Successful Biotech Entrepreneurs in the UK

France’s 2nd Biggest Pharma Enters New Partnership for Immunotherapies

What’s the Gold Standard for Therapeutic Antibodies?

Subscribe to our newsletter to get the latest biotech news!

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!